Skip to main content
Clinical Trials/NCT01729702
NCT01729702CompletedNot Applicable

Evaluation at Rest and Exercise of Clinical, Ultrasonic and Neurohormonal Parameters in Hypertrophic Cardiomyopathies

French Cardiology Society1 site in 1 country131 target enrollmentStarted: April 1, 2009Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
131
Locations
1
Primary Endpoint
Plasmatic Neurohormonal measures: BNP - NT ProBNP - Troponine

Study Overview

Brief Summary

The primary purpose of this study is to demonstrate that changes in plasma levels of circulating neurohormones (mainly BNP and NT-proBNP), measured at rest and post-exercise correlate with exercise functional limitation (assessed by exercise peak VO2) and exercise ultrasonic parameters (as left ventricular filling, obstruction, and mitral regurgitation)

Detailed Description

The secondary purposes are to study the kinetics of secretions of natriuretic peptides, and their relationships with extent of MRI myocardial fibrosis with the degree of exercise functional limitation.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
18 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •- Age 18 to 75 years
  • •Primary (sarcomeric) hypertrophic cardiomyopathy, obstructive or non obstructive, with studies of exercise peak oxygen consumption and cardiac MRI with gadolinium late-enhancement
  • •Informed consent
  • •Patient with a social insurance Patient at rest
  • •- Age 18 to 75 years
  • •Primary (sarcomeric) hypertrophic cardiomyopathy, obstructive or non obstructive
  • •Informed consent
  • •Patient with a social insurance

Exclusion Criteria

  • •- Insufficient echogenicity
  • •Permanent atrial fibrillation
  • •Complete BBB on the ECG
  • •LVEF < 35 %
  • •Previous septal ablation (surgical or percutaneous)
  • •Simultaneous participation to another biomedical research
  • •If exercise needed:
  • •contraindication to exercise : hemodynamic instability, uncontrolled high blood pressure (>220/120 mmHg), severe aortic stenosis
  • •Inability to exercise (muscular, pulmonary, elderly patient)

Arms & Interventions

single group - consecutive patients

Other

Intervention: blood sample collection (Other)

Outcomes

Primary Outcomes

Plasmatic Neurohormonal measures: BNP - NT ProBNP - Troponine

Time Frame: Day 1 at rest and during exercise

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
French Cardiology Society
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials